275 related articles for article (PubMed ID: 36601347)
1. From acute SARS-CoV-2 infection to pulmonary hypertension.
Eroume À Egom E; Shiwani HA; Nouthe B
Front Physiol; 2022; 13():1023758. PubMed ID: 36601347
[TBL] [Abstract][Full Text] [Related]
2. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective.
Halawa S; Pullamsetti SS; Bangham CRM; Stenmark KR; Dorfmüller P; Frid MG; Butrous G; Morrell NW; de Jesus Perez VA; Stuart DI; O'Gallagher K; Shah AM; Aguib Y; Yacoub MH
Nat Rev Cardiol; 2022 May; 19(5):314-331. PubMed ID: 34873286
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 patients may become predisposed to pulmonary arterial hypertension.
Suzuki YJ; Nikolaienko SI; Shults NV; Gychka SG
Med Hypotheses; 2021 Feb; 147():110483. PubMed ID: 33444904
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review.
Riou M; Coste F; Meyer A; Enache I; Talha S; Charloux A; Reboul C; Geny B
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732160
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Hypertensive Changes Secondary to COVID-19 Pneumonia in a Chronically SARS-CoV-2-Infected Bilateral Lung Explant.
Rohr JM; Strah H; Berkheim D; Siddique A; Radio SJ; Swanson BJ
Int J Surg Pathol; 2022 Jun; 30(4):443-447. PubMed ID: 34894817
[TBL] [Abstract][Full Text] [Related]
6. At a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease.
Cascino TM; Desai AA; Kanthi Y
Curr Opin Pulm Med; 2021 Sep; 27(5):342-349. PubMed ID: 34127622
[TBL] [Abstract][Full Text] [Related]
7. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
8. Long COVID syndrome after SARS-CoV-2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Wieteska-Miłek M; Kuśmierczyk-Droszcz B; Betkier-Lipińska K; Szmit S; Florczyk M; Zieliński P; Hoffman P; Krzesińki P; Kurzyna M
Pulm Circ; 2023 Apr; 13(2):e12244. PubMed ID: 37266140
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary vascular system: A vulnerable target for COVID-19.
Ai J; Hong W; Wu M; Wei X
MedComm (2020); 2021 Dec; 2(4):531-547. PubMed ID: 34909758
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
Zheng Z; Peng F; Zhou Y
Chin Med J Pulm Crit Care Med; 2023 Jun; 1(2):77-83. PubMed ID: 37388822
[TBL] [Abstract][Full Text] [Related]
11. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
Front Immunol; 2020; 11():1949. PubMed ID: 32849654
[TBL] [Abstract][Full Text] [Related]
12. COVID-19: from an acute to chronic disease? Potential long-term health consequences.
Higgins V; Sohaei D; Diamandis EP; Prassas I
Crit Rev Clin Lab Sci; 2021 Aug; 58(5):297-310. PubMed ID: 33347790
[TBL] [Abstract][Full Text] [Related]
13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
Montani D; Certain MC; Weatherald J; Jaïs X; Bulifon S; Noel-Savina E; Nieves A; Renard S; Traclet J; Bouvaist H; Riou M; de Groote P; Moceri P; Bertoletti L; Favrolt N; Guillaumot A; Jutant EM; Beurnier A; Boucly A; Ebstein N; Jevnikar M; Pichon J; Keddache S; Preda M; Roche A; Solinas S; Seferian A; Reynaud-Gaubert M; Cottin V; Savale L; Humbert M; Sitbon O;
Am J Respir Crit Care Med; 2022 Sep; 206(5):573-583. PubMed ID: 35549842
[No Abstract] [Full Text] [Related]
15. The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.
Serati A; Keshmiri MS; Shafaghi S; Mohammad MM; Kashani BS; Naghashzadeh F; Mohamadifar A; Shafaghi M; Noorali S; Hajimoradi M; Astani B; Aghdasi S; Riahi M; Alavi S; Malek R; Movahed MR
Crit Pathw Cardiol; 2023 Jun; 22(2):60-64. PubMed ID: 37220659
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody therapy in COVID-19.
Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Hypertension and COVID-19.
Castiglione L; Droppa M
Hamostaseologie; 2022 Aug; 42(4):230-238. PubMed ID: 34933375
[TBL] [Abstract][Full Text] [Related]
18. Return-to-work, disabilities and occupational health in the age of COVID-19.
Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences.
Martínez-Salazar B; Holwerda M; Stüdle C; Piragyte I; Mercader N; Engelhardt B; Rieben R; Döring Y
Front Cell Dev Biol; 2022; 10():824851. PubMed ID: 35242762
[TBL] [Abstract][Full Text] [Related]
20. Acute and Long-Term Consequences of COVID-19 on Arterial Stiffness-A Narrative Review.
Zota IM; Stătescu C; Sascău RA; Roca M; Anghel L; Maștaleru A; Leon-Constantin MM; Ghiciuc CM; Cozma SR; Dima-Cozma LC; Esanu IM; Mitu F
Life (Basel); 2022 May; 12(6):. PubMed ID: 35743812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
